January 30, 2023
New IAVI white paper identifies critical gaps across R&D, equitable access, and financing.
Features
This EGM characterizes the evidence base of SBCC interventions for strengthening HIV prevention and research among AGYW in LMICs.
January 19, 2023
Janssen-sponsored trial discontinued due to lack of efficacy.
January 11, 2023
Reflecting on the Ebola Sudan outbreak in Uganda, Swati Gupta suggests a global solution to prepare for emerging infectious disease outbreaks.
December 21, 2022
Blog perspective from a graduate of the first cohort of the IAVI ADVANCE Leadership Development Program.
December 20, 2022
First shipment of IAVI’s Sudan virus (SUDV) vaccine candidate has arrived in Entebbe, Uganda.
December 20, 2022
Sustaining momentum in research, development, and innovation for HIV prevention and other disease areas in the context of shrinking global resources. ...
In the wake of cutting-edge science, it is essential to nurture a community-rooted and participant-centered approach to accelerate vaccine research.
Jama Dalel, Ph.D., post-doctoral researcher, IAVI–Human Immunology Laboratory (HIL), Imperial College, London
Jyoti Sutar, Ph.D., senior research associate, Antibody Translational Research Program (previously the HIV Vaccine Translational Research Laboratory) ...
November 21, 2022
We must plan for their introduction and demand what is needed for new TB vaccines to reach End TB targets, experts say.
Show More
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
